Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer
Cell Reports · 2026-01 · 45 (1) · 116826
DOI: 10.1016/j.celrep.2025.116826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-01. Verfasst von Kaylyn L Devlin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Oregon Health & Science University (OHSU), Portland, OR 97201, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Drug Resistance, Neoplasm, Hepatocyte Growth Factor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHGRI NIH HHS, Knight Cancer Institute, Oregon Health and Science University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Oregon Health & Science University (OHSU), Portland, OR 97201, USA.
- Cancer Early Detection Advanced Research (CEDAR), OHSU, Portland, OR 97201, USA; Division of Oncological Sciences, OHSU, Portland, OR 97201, USA.
- Quantitative Imaging Systems LLC, Portland, OR 97210, USA.
- Department of Biomedical Engineering, Oregon Health & Science University (OHSU), Portland, OR 97201, USA; Knight Cancer Institute, OHSU, Portland, OR 97201, USA.
- Knight Cancer Institute, OHSU, Portland, OR 97201, USA; Cancer Early Detection Advanced Research (CEDAR), OHSU, Portland, OR 97201, USA; Division of Oncological Sciences, OHSU, Portland, OR 97201, USA; Department of Mol…
- Department of Biomedical Engineering, Oregon Health & Science University (OHSU), Portland, OR 97201, USA; Knight Cancer Institute, OHSU, Portland, OR 97201, USA. Electronic address: korkola@ohsu.edu.
Förderung
- NCI NIH HHS
- NHGRI NIH HHS
- Knight Cancer Institute, Oregon Health and Science University
- Prospect Creek Foundation
- National Institutes of Health National Cancer Institute
- Lady Margaret Hall, University of Oxford
- National Institutes of Health
- Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University
Zitieren
APA
Devlin, K. L., Smith, R., Bucher, E., Dane, M., Bowman, C. L., Carlson, E. J., Kilburn, D., Sudar, D., Feiler, H. S., Heiser, L. M., Langer, E. M., & Korkola, J. E. (2026). Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer. Cell Reports, 45(1), 116826. https://doi.org/10.1016/j.celrep.2025.116826
Vancouver
Devlin KL, Smith R, Bucher E, Dane M, Bowman CL, Carlson EJ, et al. Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer. Cell Reports. 2026;45(1):116826. doi:10.1016/j.celrep.2025.116826
BibTeX
@article{Devlin2026,
author = {Devlin, Kaylyn L and Smith, Rebecca and Bucher, Elmar and Dane, Mark and Bowman, Chloe L and Carlson, Eric J and Kilburn, David and Sudar, Damir and Feiler, Heidi S and Heiser, Laura M and Langer, Ellen M and Korkola, James E},
title = {Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {1},
pages = {116826},
doi = {10.1016/j.celrep.2025.116826}
}
EUVIMED